Treating Hair Loss in Skin of Color: OTC and Procedural Alopecia Solutions
Managing hair loss in patients with skin of color requires a nuanced understanding of both medical and supplemental therapies. In a detailed presentation, Maryanne Senna, MD, explored the evidence behind over-the-counter (OTC) and procedural interventions for various alopecias. As patients increasingly seek supplemental and at-home options, clinicians must be equipped to distinguish between scie …
Managing hair loss in patients with skin of color requires a nuanced understanding of both medical and supplemental therapies. In a detailed presentation, Maryanne Senna, MD, explored the evidence behind over-the-counter (OTC) and procedural interventions for various alopecias. As patients increasingly seek supplemental and at-home options, clinicians must be equipped to distinguish between scie … Continue reading "Treating Hair Loss in Skin of Color: OTC and Procedural Alopecia Solutions"
Antihistamines, particularly second-generation histamine H1-receptor antagonists, are widely used in dermatology due to their antihistaminic activity and favorable safety profile characterized by minimal sedation compared with first-generation agents. They primarily act as peripheral H1-receptor antagonists, reducing histamine-mediated effects such as vasodilation, increased vascular permeability, … 
Dermatologists must become comfortable prescribing JAK inhibitors in patients with skin of color in order to provide high-quality dermatologic care. That’s according to Dr. Brett King, a dermatologist in Fairfield, Conn., who was the first dermatologist to show that JAK inhibitors as a medicine class were effective in treating a spectrum of dermatologic conditions, including alopecia areata and … 
Scalp biopsies are an important tool in diagnosing central centrifugal cicatricial alopecia (CCCA), especially in atypical presentations where making an accurate diagnosis through other means is challenging. Even though a biopsy-confirmed diagnosis could lead to hair-saving treatment, hair loss patients sometimes balk at the recommendation to biopsy. The authors of a brief communication published … 
Dr. Cheri Frey recently delivered an insightful lecture on the evolving landscapes of cosmeceuticals and regenerative medicine. Her presentation addressed the complexities of a crowded market, emerging trends like “prejuvenation,” and the unique biological considerations for treating aging in patients with skin of color.
Navigating the Cosmeceutical Landscape
Dr. Frey acknowledged that t …